Skip to content

Investor Relations / Events & Presentations

Events & Presentations

Featured Events

There are currently no events to display.

Upcoming Events

There are currently no events to display.

Archived Events

Date Event Details
Summary Toggle Dec 5, 2018
2:10 PM EST

Citi’s 2018 Global Healthcare Conference

Summary Toggle Nov 27, 2018
12:05 PM EST

Evercore ISI HealthCONx Conference

Summary Toggle Nov 15, 2018
10:20 AM EST

Jefferies 2018 London Healthcare Conference

Summary Toggle Nov 10, 2018
8:15 PM EST

Webcast Discussion of Primary REDUCE-IT™ Trial Results Following Presentation at 2018 Scientific Sessions of American Heart Association

Summary Toggle Nov 1, 2018
7:30 AM EDT

Amarin Q3 Results Conference Call

Summary Toggle Oct 3, 2018
11:30 AM EDT

Cantor Global Healthcare Conference

Summary Toggle Sep 24, 2018
8:00 AM EDT

REDUCE-IT™ Topline Results Conference call link:

Summary Toggle Aug 27, 2018
8:00 AM EDT

Conference Call to Discuss Data Presented at European Society of Cardiology Congress

Summary Toggle Aug 1, 2018
7:30 AM EDT

AMARIN Q2 RESULTS CONFERENCE CALL

Summary Toggle Jun 7, 2018
8:00 AM EDT

Jefferies 2018 Global Healthcare Conference

Summary Toggle May 2, 2018
7:30 AM EDT

Amarin Q1 Results Conference Call

Summary Toggle Apr 9, 2018
4:40 AM EDT

H.C. Wainwright Global Life Sciences Conference

Summary Toggle Feb 27, 2018
7:30 AM EST

Amarin Q4 Results Conference Call

Summary Toggle Jan 10, 2018
5:00 PM PST

36th Annual J.P. Morgan Healthcare Conference

Presentations

For web links to papers supporting correlation between TG levels and cardiovascular risk, click here.

Title Date Documents

Amarin Q3 2018 Earnings Presentation

REDUCE-IT Efficacy and Safety Results and Related Disclosures

Primary REDUCE-IT ™ Trial Presentation

Investor Presentation December

Top Line Results - ANCHOR Trial

Top Line Results - MARINE Trial

copyright
© 2018, Amarin Corporation
Privacy policy  |  Disclaimer
Dublin Office
2 Pembroke House, Upper Pembroke
Street 28-32
Dublin 2, Ireland
US Investor Relations
Amarin Pharma Inc.
1430 Route 206
Bedminster, NJ 07921 USA
Telephone:
+1 908 719 1315
Fax:
+1 908 719 3012

Amarin Corporation